发明名称 Proliferation signature and prognosis for gastrointestinal cancer
摘要 Provided is a method of predicting the likelihood of long-term survival of a gastrointestinal cancer patient without the recurrence of gastrointestinal cancer, comprising determining the expression level of one or more prognostic RNA transcripts or their expression products in a gastrointestinal sample obtained from the patient, normalized against the expression level of all RNA transcripts or their products in the gastrointestinal cancer tissue sample, or of a reference set of RNA transcripts or their expression products; wherein the prognostic RNA transcript or expression product comprises the transcript of replication factor (activator 1) 4 (RFC4); and establishing likelihood of long-term survival without gastrointestinal cancer recurrence wherein increased expression of the one or more prognostic RNA transcripts or their expression products indicates an increased likelihood of long-term survival without gastrointestinal cancer recurrence.
申请公布号 NZ562237(A) 申请公布日期 2011.02.25
申请号 NZ20070562237 申请日期 2007.10.05
申请人 PACIFIC EDGE BIOTECHNOLOGY LTD 发明人 ANJOMSHOAA, AHMAD;REEVE, ANTHONY EDMUND;LIN, YU-HSIN;BLACK, MICHAEL A
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项
地址